SCHEMBL22605805

SCHEMBL22605805

O=C(Cc1ccc(C(F)(F)F)cc1)N1CCC(n2cc[nH]c2=O)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 2/20 0.48
▸ ME2 P23368 1/20 0.48
▸ ME1 P48163 1/20 0.48
▸ ME3 Q16798 1/20 0.48
▸ CNR1 P21554 5/20 0.46
▸ MLNR O43193 1/20 0.45
▸ OPRD1 P41143 1/20 0.43
▸ F10 P00742 1/20 0.43
▸ CALCRL Q16602 1/20 0.42
▸ JAK2 O60674 1/20 0.41
▸ JAK1 P23458 1/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ HSD11B1 P28845 1/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22587942 0.77 HRH3 (0.50) HRH3ME2ME1ME3CNR1
SCHEMBL22588108 0.76 HRH3 (0.59) HRH3ME2ME1ME3CNR1
SCHEMBL22605639 0.76 HRH3 (0.62) HRH3ME2ME1ME3CNR1
SCHEMBL28538566 0.75 HRH3 (0.52) HRH3ME2ME1ME3CNR1
SCHEMBL28535221 0.75 HRH3 (0.50) HRH3ME2ME1ME3CNR1
SCHEMBL22605908 0.75 HRH3 (0.58) HRH3ME2ME1ME3CNR1
SCHEMBL22588006 0.74 HSD11B1 (0.58) HRH3ME2ME1ME3CNR1
SCHEMBL22594434 0.74 HSD11B1 (0.73) HSD11B1CYP3A4
SCHEMBL22588037 0.74 HSD11B1 (0.58) HRH3ME2ME1ME3CNR1
SCHEMBL30317157 0.74 HSD11B1 (0.73) HSD11B1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020216378-A1 HETEROCYCLIC COMPOUND, APPLICATION THEREOF, AND COMPOSITION CONTAINING SAME 健艾仕生物医药有限公司 2020-10-29 — — WO disclosed
Send feedback